Monday, 30 July 2018

U.S. Home Infusion Therapy Market to Cross the $13.5 Billion Mark By 2024

U.S. Home Infusion Therapy Market 2018-2024: This research reviews the overall U.S. home infusion therapy industry, which according to a report, is growing at more than 10% CAGR during 2018 and 2024 to hit the $13.5bn revenue mark.
Growth Drivers:
  • A Growing hospital acquired infections
  • Rising prevalence of chronic diseases
  • Advancements in technology
  • Growing geriatric population
  • Presence of homecare facilities
Request for a sample of this research report -
Segmentations covered under U.S. Home Infusion Therapy Market Report:
  1. Based on Product:
Infusion pumps, Intravenous sets, IV cannulas & Needleless connectors
  1. Based on Application:
Anti-infectives, Hydration therapy, Chemotherapy, Enteral nutrition, Parenteral nutrition, Specialty pharmaceuticals & Others
Key Data Points from U.S. Home Infusion Therapy Market Analysis:
Increasing rates of hospital acquired infections have impacted the market growth positively.
Increasing number of immunocompromised patients that are more prone to infections will fuel industry growth over the coming years.
Infusion pumps accounted for largest revenue share in 2017 due to rising number of baby boomers, highly susceptible to suffer from infections and requires continuous delivery of fluids for maintaining proper health.
Anti-infectives business segment dominated the home infusion therapy market in 2017 and will witness similar trend in upcoming years owing to increasing prevalence of bacterial, viral and fungal infections.
The North East region will experience significant market growth due to an increase in bacterial and fungal infections stimulating demand for home infusion therapy.
Regional Data Coverage under U.S. Home Infusion Therapy Market:
  1. East North Central (Illinois, Indiana, Michigan, Ohio & Wisconsin)
  2. West South Central (Arkansas, Louisiana, Oklahoma, & Texas)
  3. South Atlantic (Delaware, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Washington D.C.)
  4. North East (Connecticut, Maine, Massachusetts, New Hampshire, Rhode Islands, Vermont, New Jersey, New York & Pennsylvania)
  5. East South Central (Alabama, Kentucky, Mississippi & Tennessee)
  6. West North Central (Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, & South Dakota)
  7. Pacific Central (Alaska, California, Hawaii, Oregon, & Washington)
  8. Mountain States (Arizona, Colorado, Utah, Nevada, New Mexico, Idaho, Montana, & Wyoming)
Key Company Profiled in this Research Report:
Amsino International, Inc, Baxter International, Inc, B.Braun Melsungen AG, Becton Dickinson, Caesarea Medical Electronics, Fresenius Kabi, Halyard Health, Inc, ICU Medical Inc, Moog Inc, Smiths Medical & Terumo Corporation.
Key Chapters Covered:
  • Methodology
  • Executive Summary
  • U.S. Home Infusion Therapy Industry Insights
  • U.S. Home Infusion Therapy Market, By Product
  • U.S. Home Infusion Therapy Market, By Application
  • U.S. Home Infusion Therapy Market, By Region
  • Company Profiles

No comments:

Post a Comment